Loading...

INO INOVIO PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

NV P

N

INOVIO PHARMACEUTICALS INC

(INO)

2024 8-K

Financial Results

Stock Offering Details

Sales Agreement Termination

Financial Results Announcement

Warrant Amendment

FDA BLA Acceptance

Stock Offering Announcement

8-K Filing Summary

Equity Offerings

Financial Statements

Financial Results

Financial Results

Financial Results Announcement

Grant of Performance-Based ...

Financial Results Announcement

Underwriting Agreement for ...

Reverse Stock Split

Stock Split and Amendment A...

Financial Results Announcement

FDA Feedback on Clinical Tr...

Financial Results Announcement

Settlement of Stockholder D...

Compensation Committee adop...

Earnings Reports

Financial Results Announcement

Costs Associated with Exit ...

External Links:

Inovio Pharmaceuticals has entered into an agreement to potentially sell up to $60 million of its common stock through Oppenheimer & Co. Inc., with the sales agent earning a commission of up to 3% on sales.

AI Assistant

INOVIO PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.